Ann H. Partridge

Ann H. Partridge, MD, MPH, is an academic leader in medical oncology, serving as Interim Chair of the Department of Medical Oncology at Dana-Farber Cancer Institute and Professor at Harvard Medical School. She directs the Adult Survivorship Program and co-founded the Program for Young Adults with Breast Cancer. Her academic rank is Professor, and she holds the Eric P. Winer, MD Chair in Breast Cancer Research. Dr. Partridge specializes in clinical research focused on improving outcomes for young adults with breast cancer, particularly addressing fertility preservation, survivorship care, and tailored therapies. She has held leadership roles in organizations like the American Society of Clinical Oncology (ASCO) and the National Cancer Institute (NCI).

Education: Earned her BS from Georgetown University, MD from Cornell University Medical College, and MPH from Harvard School of Public Health. Completed residency at the University of Pennsylvania School of Medicine.

Research: Her work emphasizes young-onset breast cancer biology, survivorship challenges, and fertility-related concerns. Key areas include pregnancy safety post-treatment, supportive care optimization, and clinical trials for targeted therapies. Over 200 peer-reviewed publications highlight her contributions to oncology.

Awards: Recognized with prestigious honors including the White House Champions of Change Award, AACR Outstanding Investigator Award, and ESMO Award 2024 for breast cancer advancements.

Grants & Teams: Research funded by NCI, Breast Cancer Research Foundation (BCRF), Susan G. Komen, and the American Cancer Society. Leads multidisciplinary teams at Dana-Farber's Young Women's Breast Cancer Study (YWS) and Survivorship programs.

Labs/Teams: Directs the Program for Young Adults with Breast Cancer and co-leads the NCI Alliance Breast Committee, fostering collaborative survivorship initiatives and clinical innovation.